nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.228	0.325	CbGbCtD
Trabectedin—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.19	0.27	CbGbCtD
Trabectedin—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.174	0.247	CbGbCtD
Trabectedin—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.11	0.157	CbGbCtD
Trabectedin—Traumatic liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00943	0.0941	CcSEcCtD
Trabectedin—PTGS1—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00763	0.0387	CbGpPWpGaD
Trabectedin—SRC—EPHA-mediated growth cone collapse—MYH10—focal segmental glomerulosclerosis	0.00671	0.034	CbGpPWpGaD
Trabectedin—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—VLDLR—focal segmental glomerulosclerosis	0.0054	0.0274	CbGpPWpGaD
Trabectedin—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.00455	0.0454	CcSEcCtD
Trabectedin—SRC—Signaling events mediated by TCPTP—PIAS1—focal segmental glomerulosclerosis	0.00436	0.0221	CbGpPWpGaD
Trabectedin—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.0417	CcSEcCtD
Trabectedin—SRC—Interleukin-11 Signaling Pathway—PIAS1—focal segmental glomerulosclerosis	0.00404	0.0205	CbGpPWpGaD
Trabectedin—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00397	0.0396	CcSEcCtD
Trabectedin—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00386	0.0385	CcSEcCtD
Trabectedin—SRC—Signaling events mediated by focal adhesion kinase—ACTN4—focal segmental glomerulosclerosis	0.0037	0.0187	CbGpPWpGaD
Trabectedin—SRC—EPHA-mediated growth cone collapse—MYH9—focal segmental glomerulosclerosis	0.00367	0.0186	CbGpPWpGaD
Trabectedin—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00305	0.0304	CcSEcCtD
Trabectedin—SRC—Integrins in angiogenesis—COL4A4—focal segmental glomerulosclerosis	0.00303	0.0153	CbGpPWpGaD
Trabectedin—SRC—S1P3 pathway—GNAQ—focal segmental glomerulosclerosis	0.00303	0.0153	CbGpPWpGaD
Trabectedin—SRC—ADP signalling through P2Y purinoceptor 1—GNAQ—focal segmental glomerulosclerosis	0.00303	0.0153	CbGpPWpGaD
Trabectedin—SRC—EPH-Ephrin signaling—MYH10—focal segmental glomerulosclerosis	0.00297	0.0151	CbGpPWpGaD
Trabectedin—SRC—NCAM signaling for neurite out-growth—COL4A4—focal segmental glomerulosclerosis	0.00285	0.0144	CbGpPWpGaD
Trabectedin—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.0283	CcSEcCtD
Trabectedin—SRC—Integrins in angiogenesis—COL4A1—focal segmental glomerulosclerosis	0.00278	0.0141	CbGpPWpGaD
Trabectedin—SRC—p130Cas linkage to MAPK signaling for integrins—FN1—focal segmental glomerulosclerosis	0.00271	0.0137	CbGpPWpGaD
Trabectedin—SRC—GRB2:SOS provides linkage to MAPK signaling for Integrins—FN1—focal segmental glomerulosclerosis	0.00271	0.0137	CbGpPWpGaD
Trabectedin—SRC—NCAM signaling for neurite out-growth—COL4A1—focal segmental glomerulosclerosis	0.00262	0.0133	CbGpPWpGaD
Trabectedin—SRC—Signal amplification—GNAQ—focal segmental glomerulosclerosis	0.00255	0.0129	CbGpPWpGaD
Trabectedin—SRC—Thrombin signalling through proteinase activated receptors (PARs)—GNAQ—focal segmental glomerulosclerosis	0.00249	0.0126	CbGpPWpGaD
Trabectedin—SRC—Netrin-1 signaling—TRPC6—focal segmental glomerulosclerosis	0.00239	0.0121	CbGpPWpGaD
Trabectedin—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.0238	CcSEcCtD
Trabectedin—PTGS1—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.00236	0.012	CbGpPWpGaD
Trabectedin—SRC—Integrins in angiogenesis—COL4A3—focal segmental glomerulosclerosis	0.00235	0.0119	CbGpPWpGaD
Trabectedin—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.0232	CcSEcCtD
Trabectedin—SRC—Arf6 signaling events—GNAQ—focal segmental glomerulosclerosis	0.00231	0.0117	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—PIAS1—focal segmental glomerulosclerosis	0.0023	0.0116	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—ANGPT2—focal segmental glomerulosclerosis	0.0023	0.0116	CbGpPWpGaD
Trabectedin—SRC—NCAM signaling for neurite out-growth—COL4A3—focal segmental glomerulosclerosis	0.00221	0.0112	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—ACTA2—focal segmental glomerulosclerosis	0.00216	0.011	CbGpPWpGaD
Trabectedin—SRC—Alpha9 beta1 integrin signaling events—SPP1—focal segmental glomerulosclerosis	0.00216	0.0109	CbGpPWpGaD
Trabectedin—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.00213	0.0108	CbGpPWpGaD
Trabectedin—SRC—Arf6 signaling events—AGTR1—focal segmental glomerulosclerosis	0.00212	0.0107	CbGpPWpGaD
Trabectedin—SRC—Cell-Cell communication—CD2AP—focal segmental glomerulosclerosis	0.0021	0.0106	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—ACTN4—focal segmental glomerulosclerosis	0.00208	0.0106	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by PRL—AGT—focal segmental glomerulosclerosis	0.00208	0.0106	CbGpPWpGaD
Trabectedin—SRC—Plasma membrane estrogen receptor signaling—GNAQ—focal segmental glomerulosclerosis	0.00204	0.0103	CbGpPWpGaD
Trabectedin—SRC—Cell-Cell communication—ACTN4—focal segmental glomerulosclerosis	0.00202	0.0102	CbGpPWpGaD
Trabectedin—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.0199	CcSEcCtD
Trabectedin—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.0196	CcSEcCtD
Trabectedin—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.0196	CcSEcCtD
Trabectedin—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.0191	CcSEcCtD
Trabectedin—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.0191	CcSEcCtD
Trabectedin—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.0185	CcSEcCtD
Trabectedin—SRC—Fcgamma receptor (FCGR) dependent phagocytosis—MYH9—focal segmental glomerulosclerosis	0.00183	0.0093	CbGpPWpGaD
Trabectedin—SRC—Alpha9 beta1 integrin signaling events—FN1—focal segmental glomerulosclerosis	0.0018	0.00913	CbGpPWpGaD
Trabectedin—SRC—Alpha9 beta1 integrin signaling events—NOS2—focal segmental glomerulosclerosis	0.00178	0.00902	CbGpPWpGaD
Trabectedin—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.0177	CcSEcCtD
Trabectedin—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.0176	CcSEcCtD
Trabectedin—SRC—Cell-Cell communication—NPHS1—focal segmental glomerulosclerosis	0.00174	0.00881	CbGpPWpGaD
Trabectedin—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.0173	CcSEcCtD
Trabectedin—SRC—Endothelins—TRPC6—focal segmental glomerulosclerosis	0.00173	0.00876	CbGpPWpGaD
Trabectedin—SRC—Alpha4 beta1 integrin signaling events—SPP1—focal segmental glomerulosclerosis	0.00173	0.00876	CbGpPWpGaD
Trabectedin—SRC—Integrin alphaIIb beta3 signaling—FN1—focal segmental glomerulosclerosis	0.00169	0.00858	CbGpPWpGaD
Trabectedin—SRC—Cell surface interactions at the vascular wall—ANGPT2—focal segmental glomerulosclerosis	0.00168	0.00852	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—PIAS1—focal segmental glomerulosclerosis	0.00168	0.00849	CbGpPWpGaD
Trabectedin—SRC—Nanoparticle-mediated activation of receptor signaling—FN1—focal segmental glomerulosclerosis	0.00164	0.00834	CbGpPWpGaD
Trabectedin—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.0163	CcSEcCtD
Trabectedin—SRC—EPH-Ephrin signaling—MYH9—focal segmental glomerulosclerosis	0.00163	0.00825	CbGpPWpGaD
Trabectedin—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.016	CcSEcCtD
Trabectedin—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.0159	CcSEcCtD
Trabectedin—SRC—Thromboxane A2 receptor signaling—GNAQ—focal segmental glomerulosclerosis	0.00159	0.00805	CbGpPWpGaD
Trabectedin—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.0156	CcSEcCtD
Trabectedin—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.0154	CcSEcCtD
Trabectedin—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.0153	CcSEcCtD
Trabectedin—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.015	CcSEcCtD
Trabectedin—SRC—Endothelins—GNAQ—focal segmental glomerulosclerosis	0.00145	0.00733	CbGpPWpGaD
Trabectedin—SRC—Alpha4 beta1 integrin signaling events—FN1—focal segmental glomerulosclerosis	0.00144	0.00731	CbGpPWpGaD
Trabectedin—SRC—LPA receptor mediated events—GNAQ—focal segmental glomerulosclerosis	0.00143	0.00723	CbGpPWpGaD
Trabectedin—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.0142	CcSEcCtD
Trabectedin—SRC—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.0014	0.00709	CbGpPWpGaD
Trabectedin—SRC—TSH signaling pathway—GNAQ—focal segmental glomerulosclerosis	0.00139	0.00706	CbGpPWpGaD
Trabectedin—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.0137	CcSEcCtD
Trabectedin—SRC—Syndecan-2-mediated signaling events—FN1—focal segmental glomerulosclerosis	0.00134	0.00682	CbGpPWpGaD
Trabectedin—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.0134	CcSEcCtD
Trabectedin—SRC—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.00132	0.00669	CbGpPWpGaD
Trabectedin—SRC—Platelet Aggregation (Plug Formation)—FN1—focal segmental glomerulosclerosis	0.00132	0.00667	CbGpPWpGaD
Trabectedin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.013	CcSEcCtD
Trabectedin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.013	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.013	CcSEcCtD
Trabectedin—SRC—Signaling by PDGF—COL4A4—focal segmental glomerulosclerosis	0.0013	0.00657	CbGpPWpGaD
Trabectedin—CYP2C19—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00126	0.00641	CbGpPWpGaD
Trabectedin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.0125	CcSEcCtD
Trabectedin—SRC—Focal Adhesion—COL4A4—focal segmental glomerulosclerosis	0.00125	0.00635	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00125	0.00632	CbGpPWpGaD
Trabectedin—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0124	CcSEcCtD
Trabectedin—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.0123	CcSEcCtD
Trabectedin—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.0122	CcSEcCtD
Trabectedin—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.0121	CcSEcCtD
Trabectedin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0119	CcSEcCtD
Trabectedin—SRC—Signaling by PDGF—COL4A1—focal segmental glomerulosclerosis	0.00119	0.00604	CbGpPWpGaD
Trabectedin—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FN1—focal segmental glomerulosclerosis	0.00119	0.00603	CbGpPWpGaD
Trabectedin—SRC—Angiogenesis—MMP9—focal segmental glomerulosclerosis	0.00119	0.00601	CbGpPWpGaD
Trabectedin—SRC—FGF signaling pathway—SPP1—focal segmental glomerulosclerosis	0.00117	0.00591	CbGpPWpGaD
Trabectedin—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00116	0.00589	CbGpPWpGaD
Trabectedin—CYP2E1—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.00116	0.00588	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—COL4A1—focal segmental glomerulosclerosis	0.00115	0.00583	CbGpPWpGaD
Trabectedin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0114	CcSEcCtD
Trabectedin—SRC—Syndecan-2-mediated signaling events—MMP2—focal segmental glomerulosclerosis	0.00114	0.00578	CbGpPWpGaD
Trabectedin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.0113	CcSEcCtD
Trabectedin—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.0112	CcSEcCtD
Trabectedin—SRC—Endothelins—EDN1—focal segmental glomerulosclerosis	0.00112	0.00568	CbGpPWpGaD
Trabectedin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.0111	CcSEcCtD
Trabectedin—SRC—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.0011	0.0056	CbGpPWpGaD
Trabectedin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.011	CcSEcCtD
Trabectedin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.0109	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.0108	CcSEcCtD
Trabectedin—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.0108	CcSEcCtD
Trabectedin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0107	CcSEcCtD
Trabectedin—SRC—Integrins in angiogenesis—SPP1—focal segmental glomerulosclerosis	0.00103	0.00522	CbGpPWpGaD
Trabectedin—SRC—Plasma membrane estrogen receptor signaling—MMP2—focal segmental glomerulosclerosis	0.00103	0.00521	CbGpPWpGaD
Trabectedin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0102	CcSEcCtD
Trabectedin—SRC—Signaling by PDGF—COL4A3—focal segmental glomerulosclerosis	0.00101	0.0051	CbGpPWpGaD
Trabectedin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000991	0.00988	CcSEcCtD
Trabectedin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000991	0.00988	CcSEcCtD
Trabectedin—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—focal segmental glomerulosclerosis	0.000989	0.00501	CbGpPWpGaD
Trabectedin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000923	0.00921	CcSEcCtD
Trabectedin—SRC—Glypican 1 network—TGFB1—focal segmental glomerulosclerosis	0.000917	0.00465	CbGpPWpGaD
Trabectedin—SRC—EPH-ephrin mediated repulsion of cells—MMP2—focal segmental glomerulosclerosis	0.000906	0.00459	CbGpPWpGaD
Trabectedin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000899	0.00897	CcSEcCtD
Trabectedin—SRC—Integrins in angiogenesis—FN1—focal segmental glomerulosclerosis	0.00086	0.00436	CbGpPWpGaD
Trabectedin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000857	0.00856	CcSEcCtD
Trabectedin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000829	0.00827	CcSEcCtD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000823	0.00417	CbGpPWpGaD
Trabectedin—SRC—AGE/RAGE pathway—NOS2—focal segmental glomerulosclerosis	0.000818	0.00415	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—FN1—focal segmental glomerulosclerosis	0.000818	0.00415	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.000817	0.00414	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—NOS2—focal segmental glomerulosclerosis	0.000809	0.0041	CbGpPWpGaD
Trabectedin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000797	0.00795	CcSEcCtD
Trabectedin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00079	0.00788	CcSEcCtD
Trabectedin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000789	0.00788	CcSEcCtD
Trabectedin—SRC—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.000788	0.00399	CbGpPWpGaD
Trabectedin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000785	0.00783	CcSEcCtD
Trabectedin—SRC—Plasma membrane estrogen receptor signaling—MMP9—focal segmental glomerulosclerosis	0.000773	0.00392	CbGpPWpGaD
Trabectedin—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—focal segmental glomerulosclerosis	0.000758	0.00384	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.000751	0.00381	CbGpPWpGaD
Trabectedin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000744	0.00743	CcSEcCtD
Trabectedin—SRC—LPA receptor mediated events—MMP2—focal segmental glomerulosclerosis	0.00072	0.00365	CbGpPWpGaD
Trabectedin—SRC—Syndecan-2-mediated signaling events—TGFB1—focal segmental glomerulosclerosis	0.000707	0.00358	CbGpPWpGaD
Trabectedin—SRC—AGE/RAGE pathway—MMP2—focal segmental glomerulosclerosis	0.000702	0.00356	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000698	0.00354	CbGpPWpGaD
Trabectedin—SRC—EPH-ephrin mediated repulsion of cells—MMP9—focal segmental glomerulosclerosis	0.000681	0.00345	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.000681	0.00345	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—PCNA—focal segmental glomerulosclerosis	0.000672	0.00341	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.000634	0.00322	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.000634	0.00321	CbGpPWpGaD
Trabectedin—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—focal segmental glomerulosclerosis	0.000625	0.00317	CbGpPWpGaD
Trabectedin—SRC—FGF signaling pathway—MMP9—focal segmental glomerulosclerosis	0.00062	0.00314	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.000605	0.00307	CbGpPWpGaD
Trabectedin—SRC—Interleukin-11 Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000602	0.00305	CbGpPWpGaD
Trabectedin—SRC—Cell surface interactions at the vascular wall—FN1—focal segmental glomerulosclerosis	0.000599	0.00303	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000583	0.00296	CbGpPWpGaD
Trabectedin—SRC—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000581	0.00294	CbGpPWpGaD
Trabectedin—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000576	0.00292	CbGpPWpGaD
Trabectedin—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000574	0.00291	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—FN1—focal segmental glomerulosclerosis	0.000571	0.0029	CbGpPWpGaD
Trabectedin—SRC—IL-3 Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000552	0.0028	CbGpPWpGaD
Trabectedin—SRC—LPA receptor mediated events—MMP9—focal segmental glomerulosclerosis	0.000541	0.00274	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000536	0.00272	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—SPP1—focal segmental glomerulosclerosis	0.000532	0.00269	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.00053	0.00268	CbGpPWpGaD
Trabectedin—SRC—EPH-Ephrin signaling—MMP2—focal segmental glomerulosclerosis	0.000529	0.00268	CbGpPWpGaD
Trabectedin—SRC—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.000528	0.00268	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—FN1—focal segmental glomerulosclerosis	0.000476	0.00241	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—SERPINE1—focal segmental glomerulosclerosis	0.000475	0.00241	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—PCNA—focal segmental glomerulosclerosis	0.000475	0.00241	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.000466	0.00236	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000456	0.00231	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000453	0.00229	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—SPP1—focal segmental glomerulosclerosis	0.000441	0.00223	CbGpPWpGaD
Trabectedin—SRC—CXCR4-mediated signaling events—MMP9—focal segmental glomerulosclerosis	0.000435	0.00221	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000432	0.00219	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—SPP1—focal segmental glomerulosclerosis	0.000426	0.00216	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000416	0.00211	CbGpPWpGaD
Trabectedin—SRC—EPH-Ephrin signaling—MMP9—focal segmental glomerulosclerosis	0.000398	0.00202	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000381	0.00193	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—FN1—focal segmental glomerulosclerosis	0.000355	0.0018	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000333	0.00169	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000327	0.00166	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000322	0.00163	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000315	0.0016	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—TGFB1—focal segmental glomerulosclerosis	0.0003	0.00152	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIAS1—focal segmental glomerulosclerosis	0.0003	0.00152	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	0.000288	0.00146	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000284	0.00144	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000273	0.00138	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000262	0.00133	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000262	0.00133	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.00025	0.00127	CbGpPWpGaD
Trabectedin—SRC—Immune System—MYH9—focal segmental glomerulosclerosis	0.000222	0.00113	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000222	0.00112	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000209	0.00106	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000197	0.000997	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000197	0.000996	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000194	0.000983	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000186	0.000942	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000186	0.000941	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000181	0.000917	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000178	0.000903	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000169	0.000858	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000168	0.000852	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000165	0.000839	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000164	0.000829	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000162	0.000823	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00016	0.000813	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000151	0.000763	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000149	0.000756	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000148	0.000749	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000143	0.000727	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.00014	0.000711	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000135	0.000685	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000135	0.000683	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD79A—focal segmental glomerulosclerosis	0.000135	0.000682	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000129	0.000654	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000126	0.00064	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000116	0.00059	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000113	0.000574	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000111	0.000561	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00011	0.000558	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD40LG—focal segmental glomerulosclerosis	0.00011	0.000556	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000107	0.000543	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000105	0.000535	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000103	0.000524	CbGpPWpGaD
Trabectedin—SRC—Disease—LPL—focal segmental glomerulosclerosis	9.94e-05	0.000504	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	9.7e-05	0.000491	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CTGF—focal segmental glomerulosclerosis	9.44e-05	0.000478	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.25e-05	0.000469	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	8.84e-05	0.000448	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	8.75e-05	0.000444	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.7e-05	0.000441	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	8.69e-05	0.000441	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TGFB1—focal segmental glomerulosclerosis	8.53e-05	0.000432	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.46e-05	0.000429	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	8.27e-05	0.000419	CbGpPWpGaD
Trabectedin—SRC—Disease—NOS2—focal segmental glomerulosclerosis	7.77e-05	0.000394	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	7.61e-05	0.000386	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	7.54e-05	0.000382	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	7.49e-05	0.00038	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	7.44e-05	0.000377	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	7.28e-05	0.000369	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.18e-05	0.000364	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.96e-05	0.000353	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	6.78e-05	0.000344	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.71e-05	0.00034	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	6.7e-05	0.000339	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	6.64e-05	0.000337	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.59e-05	0.000334	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—LPL—focal segmental glomerulosclerosis	6.54e-05	0.000332	CbGpPWpGaD
Trabectedin—SRC—Disease—SERPINE1—focal segmental glomerulosclerosis	6.54e-05	0.000331	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.17e-05	0.000313	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.12e-05	0.00031	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.96e-05	0.000302	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	5.75e-05	0.000291	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AGT—focal segmental glomerulosclerosis	5.6e-05	0.000284	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.5e-05	0.000279	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	5.05e-05	0.000256	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	4.97e-05	0.000252	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	4.64e-05	0.000235	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	4.6e-05	0.000233	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.58e-05	0.000232	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	4.38e-05	0.000222	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	4.32e-05	0.000219	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ALB—focal segmental glomerulosclerosis	4.29e-05	0.000218	CbGpPWpGaD
Trabectedin—SRC—Disease—TGFB1—focal segmental glomerulosclerosis	4.13e-05	0.000209	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.03e-05	0.000204	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	3.97e-05	0.000201	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	3.94e-05	0.0002	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.51e-05	0.000178	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	3.31e-05	0.000168	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	3.05e-05	0.000154	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	3.04e-05	0.000154	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	3.02e-05	0.000153	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.89e-05	0.000147	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.6e-05	0.000132	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.99e-05	0.000101	CbGpPWpGaD
